Reversal, by treatment with an aldose reductase inhibitor, of impaired axonal transport and motor nerve conduction velocity in experimental diabetes mellitus.
D000449:Aldehyde Reductase / Q000378:metabolism; D000818:Animals; D001370:Axonal Transport / Q000187:drug effects; D002795:Choline O-Acetyltransferase / Q000378:metabolism; D003921:Diabetes Mellitus, Experimental / Q000188:drug therapy*; D003929:Diabetic Neuropathies / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D009046:Motor Neurons; D009431:Neural Conduction / Q000187:drug effects; D011804:Quinolines / Q000627:therapeutic use*; D015363:Quinolones; D051381:Rats
D011804:Quinolines; D015363:Quinolones; C033661:ICI 105552; D000449:Aldehyde Reductase; D002795:Choline O-Acetyltransferase